MetaTOC stay on top of your field, easily

Reduction of eotaxin production and eosinophil recruitment by pulmonary autologous macrophage transfer in a cockroach-allergen induced asthma model

, , , ,

AJP Lung Cellular and Molecular Physiology

Published online on

Abstract

We sought to investigate the effects of cockroach allergen (CRA) exposure on the lung macrophage population to determine how different macrophage phenotypes influence exacerbation of disease. CRA exposure caused significantly reduced expression of CD86 on lung macrophages. These effects were not systemic as peritoneal macrophage CD86 expression was not altered. To investigate whether naïve macrophages could reduce asthma-like pulmonary inflammation, autologous peritoneal macrophages were instilled into the airways 24 hours prior to the final CRA challenge. Pulmonary inflammation was assessed by measurement of airway hyper-responsiveness, mucin production, inflammatory cell recruitment, and cytokine production. Cell transfer did not have significant effects in control mice, nor did it affect pulmonary mucin production or airway hyper-responsiveness in control or CRA-exposed mice. However, there was significant reduction in the number of eosinophils recovered in the BAL (5.8x105 vs. 0.88x105), and total cell recruitment to the airways of CRA-exposed mice was markedly reduced (1.1x106 vs. 0.57x106). The reduced eosinophil recruitment was reflected by substantially lower levels of eosinophil peroxidase in the lung, and significantly lower concentrations of eotaxins in BAL (eotaxin 1: 3 pg/ml vs. undetectable; eotaxin 2: 2383 vs. 131 pg/ml) and lung homogenate (eotaxin 1: 1043 vs. 218 pg/ml; eotaxin 2: 10 vs. 1.5 ng/ml). We conclude that CRA decreases lung macrophage CD86 expression. Furthermore, supplementation of the lung cell population with peritoneal macrophages inhibits eosinophil recruitment, achieved through reduction of eotaxin production. These data demonstrate that transfer of naïve macrophages will reduce some aspects of asthma-like pulmonary inflammation in response to CRA.